8 December 2016 – Astana, Kazakhstan – The Resolution that summarizes recommendations for the migrant-specific patient-oriented approach to address TB in the Central Asian Region was adopted today at the conclusion of a two-day meeting. It brought together government officials, representatives of National TB programs, international NGOs and civil society, migration authorities and partners from the Central Asian countries of Kyrgyzstan, Tajikistan, Uzbekistan, Kazakhstan, Russia, Ukraine and Armenia.

07 November 2016 - Geneva, Switzerland - The Stop TB Partnership and its partners are pleased to announce the launch of a social impact fund called Venture Lab (vLAB), which will pool and blend private and public capital to address systemic barriers in the TB space. The organization also announced that one of its Private Sector Constituency members has made an initial donation to the fund.

On July 16 the Stop TB Partnership and Médecins Sans Frontières launched Step up for TB campaign calling on all countries to update their TB policies in line with the latest WHO policies within 500 days.

Global Fund and USAID financing supports procurement of the new pediatric formulation in India through the Stop TB Partnership’s Global Drug Facility

Dear Partners, Colleagues and Friends,

The Stop TB Partnership is currently recruiting an Advocacy Specialist to join its Advocacy and Communications Team.

The new child-friendly pediatric TB formulations are being successfully rolled out globally in 27 countries by the Stop TB Partnership’s Global Drug Facility.

28 September 2016, Geneva, Switzerland - The Stop TB Partnership received over 530 proposals, with a total ask of more than USD 266 million, in response to its recent funding call through the TB REACH grants platform. This is an unprecedented level of interest from the overall TB community for funding innovations in service delivery.

The High-Level Meeting would bring together Heads of States, political leaders, U.N. agencies, and people affected by TB to push for a renewed and well-funded global response at the highest political levels in order to end TB.

The Stop TB Partnership's Global Drug Facility (GDF) has published its 2016 Catalogue. The catalogue details prices and descriptions of products that can be ordered through GDF. Countries and programmes that enable health care providers to treat patients according to the latest WHO treatment guidelines can procure quality-assured products through GDF.